WARTS
Clinical trials for WARTS explained in plain language.
Never miss a new study
Get alerted when new WARTS trials appear
Sign up with your email to follow new studies for WARTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stubborn warts: extended treatment shows promise
Disease control Recruiting nowThis study follows people who already took part in earlier trials for common warts. They can receive up to 4 more treatments with YCANTH, a liquid applied to each wart every 21 days. The goal is to see if the treatment is safe and can clear all warts over about a year. Around 600…
Matched conditions: WARTS
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 06:29 UTC
-
New gel could zap away common warts
Disease control Recruiting nowThis study tests a gel called YCANTH on common warts caused by HPV. About 300 people aged 2 and older will apply the gel to their warts to see if it clears them completely by day 84. The goal is to find a safe and effective treatment for warts on the body.
Matched conditions: WARTS
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 06:17 UTC
-
New heated patch could zap warts away faster
Disease control Recruiting nowThis study tests whether adding a special microneedle patch (with or without hydrogen peroxide) to heat therapy can better clear viral warts. About 210 people aged 6–65 with common warts will be randomly assigned to one of three groups. The goal is to see which approach leads to …
Matched conditions: WARTS
Phase: NA • Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug trial offers hope for rare immune disorder
Disease control Recruiting nowThis study is testing whether Mozobil, a drug already used for bone marrow transplants, can safely improve white blood cell counts in adults with WHIMS syndrome. WHIMS is a rare genetic disorder that causes severe infections, warts, and low white blood cells. Researchers will giv…
Matched conditions: WARTS
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Apr 21, 2026 12:44 UTC
-
Scientists track rare immune condition to uncover its secrets
Knowledge-focused Recruiting nowThis study aims to learn more about idiopathic CD4+ lymphocytopenia (ICL), a rare condition where the body has too few CD4+ immune cells, leading to infections or autoimmune problems. Researchers will follow about 950 participants for up to 10 years, collecting medical history, b…
Matched conditions: WARTS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC